Foresite Capital Management IV

Latest statistics and disclosures from Foresite Capital Management IV's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are PHVS, KURA, SNDX, LYEL, RLAY, and represent 100.00% of Foresite Capital Management IV's stock portfolio.
  • Added to shares of these 2 stocks: RLAY (+$7.1M), PHVS.
  • Started 1 new stock position in RLAY.
  • Foresite Capital Management IV was a net buyer of stock by $9.0M.
  • Foresite Capital Management IV has $153M in assets under management (AUM), dropping by 2.79%.
  • Central Index Key (CIK): 0001704132

Tip: Access up to 7 years of quarterly data

Positions held by Foresite Capital Management IV consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Foresite Capital Management IV

Foresite Capital Management IV holds 5 positions in its portfolio as reported in the September 2024 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Pharvaris N V (PHVS) 53.2 $81M +2% 4.4M 18.52
 View chart
Kura Oncology (KURA) 23.6 $36M 1.8M 19.54
 View chart
Syndax Pharmaceuticals (SNDX) 11.0 $17M 875k 19.25
 View chart
Lyell Immunopharma (LYEL) 7.5 $12M 8.3M 1.38
 View chart
Relay Therapeutics (RLAY) 4.6 $7.1M NEW 1.0M 7.08
 View chart

Past Filings by Foresite Capital Management IV

SEC 13F filings are viewable for Foresite Capital Management IV going back to 2017

View all past filings